Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Exploring the hereditary background of renal cancer in Denmark

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Detection of PMS2 Mutations by Screening Hereditary Nonpolyposis Colon Cancer Families from Denmark and Sweden

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICT

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Genomisk medicin til præimplantations-, 
præ- og postnatal diagnostik

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Toward mechanistic models for genotype-phenotype correlations in phenylketonuria using protein stability calculations

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Subtypes in BRCA-mutated breast cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Every year more than 800 patients in Denmark are diagnosed with renal cell carcinoma (RCC) of which 3-5% are expected to be part of a hereditary renal cancer syndrome. We performed genetic screening of causative and putative RCC-genes (VHL, FH, FLCN, MET, SDHB, BAP1, MITF, CDKN2B) in RCC-patients suspected of a genetic predisposition.

METHODS: The cohort consisted of forty-eight Danish families or individuals with early onset RCC, a family history of RCC, a family history of RCC and melanoma or both RCC- and melanoma diagnosis in the same individual. DNA was extracted from peripheral blood samples or cancer-free formalin-fixed paraffin-embedded tissue.

RESULTS: One start codon variant of unknown clinical significance (VUS) (c.3G>A, p.Met1Ile) and one missense VUS (c.631A>C, p.Met211Leu) was found in VHL in a patient with RCC-onset at twenty-eight years of age but without other manifestations or family history of von Hippel-Lindau (VHL). Furthermore, in three families we found three different variants in BAP1, one of which was a novel non-segregating missense variant (c.1502G>A, p.Ser501Asn) in a family with two brothers affected with RCC. Finally, we found the known E318K-substitution in MITF in a RCC-affected member of a family with multiple melanomas. No variants were detected in CDKN2B.

CONCLUSION: Although we did find three VUS's in BAP1 in three families and a pathogenic variant in MITF in one family, pathogenic germline variants in BAP1, MITF or CDKN2B are not frequent causes of hereditary renal cancer in Denmark. It is possible that the high prevalence of risk factors such as male gender, smoking and obesity has influenced the development of cancer in the patients of the current study. Further investigations into putative predisposing genes and risk factors of RCC are necessary to enable better prediction of renal cancer risk or presymptomatic testing of relatives in hereditary renal cancer families.

Original languageEnglish
JournalPLoS One
Volume14
Issue number4
Pages (from-to)e0215725
ISSN1932-6203
DOIs
Publication statusPublished - 29 Apr 2019

ID: 58280279